Franklin Genomic Advancements ETF (HELX) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria.
HELX tiene fecha de IPO 2020-02-27, cotiza en el Chicago Board Option, una capitalización de mercado de $17.26M.
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.
